MAIA Insider Trading Activity and SEC Form 4 Filings
MAIA insider trading summary
Over the past 12 months, insiders at MAIA Biotechnology, Inc. (MAIA) reported 27 open-market purchases worth $986K by 7 insiders and no sales on SEC Form 4. Net insider buying was $986K.
Latest MAIA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Vlad Vitoc | Chief Executive Officer | Buy | $100K (73,000 @ $1.37) |
| Sep 10, 2026 | Ramiro Guerrero | Director | Buy | $50K (37,595 @ $1.32) |
| Aug 28, 2026 | Ramiro Guerrero | Director | Buy | $63K (46,620 @ $1.35) |
| Aug 27, 2026 | Ramiro Guerrero | Director | Buy | $109K (78,239 @ $1.39) |
| Aug 26, 2026 | Ramiro Guerrero | Director | Buy | $12K (8,931 @ $1.39) |
| Aug 24, 2026 | Ramiro Guerrero | Director | Buy | $2K (1,794 @ $1.33) |
| Aug 20, 2026 | Ramiro Guerrero | Director | Buy | $16K (11,899 @ $1.37) |
| Jun 1, 2026 | Vlad Vitoc | Chief Executive Officer | Buy | $101K (72,700 @ $1.39) |
| Jun 1, 2026 | Stan Smith | Director | Buy | $100K (75,000 @ $1.34) |
| Jun 1, 2026 | Sergei Gryaznov | Chief Scientific Officer | Buy | $3K (2,000 @ $1.34) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.